The rapid detection of soluble bacterial antigens in the cerebrospinal fluid (CSF) of patients with meningitis has distinct clinical advantages. A positive result can allow more precise antimicrobial therapy. The results of antigen detection tests are available at least 18 h before culture results. These tests may give positive results even when Gram stain examination and culture are negative. Furthermore, the amount of antigen in the CSF may provide valuable prognostic information (8) .
Several methods are available for antigen detection. They include counterimmunoelectrophoresis (CIE), latex agglutination (LA), coagglutination (COA), enzyme-linked immunosorbent assay, and radioimmunoassay. The last two methods are time-consuming (2 to 4 h) and are most cost efficient when specimens are processed in batches. CIE is technically difficult, requires special equipment, and is reported to be less sensitive than LA and COA for some microbial antigens (8, 10) .
The most rapid antigen tests available are LA and COA. Both suffer from possible false-positive results due to nonspecific agglutination of indicator particles by untreated biological specimens or biological cross-reactions. Until recently, comprehensive panels of reagents which detect the most common agents of bacterial meningitis were not commercially available.
Drow et al. (4) , however, have recently reported that the Phadebact CSF product, containing individual antisera to the four most common agents of bacterial meningitis, detected 74% of the positive specimens, compared with 65% detected by CIE. Ingram et al. (6) 
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MATERIALS AND METHODS
CSF specimens for analysis were chosen from those sent to the clinical laboratory for routine microbiological processing. They represented both specimens referred to and inpatient specimens from the John Dempsey Hospital, University of Connecticut Health Center. After routine processing in which each CSF sample was examined microscopically, cultured, and tested for bacterial antigens by CIE, the specimens were frozen at -70°C for later analysis. All CSF specimens positive for N. meningitidis group B were tested immediately and not frozen.
To be included in the study as a "positive" specimen, two of three tests (Gram stain, culture, or antigen detection) had to yield a positive result.
Culturing procedures. CSF samples were routinely cultured on 7.5% blood agar and on chocolate agar. The plates were incubated in a CO2 incubator for a maximum of 48 h. Colonies were identified as described previously (9) .
CIE. CIE was done as described previously (11), with 1% agarose-coated Mylar film, a Bioware electrophoresis chamber, and antiserum. H. influenzae b antiserum was from Hyland, Inc., and S. pneumoniae antiserum (Omniserum) was from the Statenserum-institut, Copenhagen, Denmark. The purified polysaccharides of H. influenzae b (obtained from D. H. Smith, University of Rochester), N. meningitidis groups A and C (meningococcal vaccine; Merck Sharpe & Dohme), and S. pneumoniae (Pneumovax) were used both as control antigens and to determine the sensitivity of the kits. All CIE films were stained wth Coomassie blue as described previously (11) . LA Although these products are currently not approved for other body fluids, many workers have used CIE, LA, and COA to detect antigen in serum and urine. Several reports confirm the diagnostic advantage of detecting antigen in urine as an adjunct to detecting it in CSF (2, 5, 7).
The advantages of LA and COA over CIE have been noted previously. The same advantages were seen in this study. The LA and COA kits are easier to use than CIE. Technologists need less training for their use, and there are fewer variables in the test procedure. The time required to perform agglutination tests (5 to 15 min) is significantly shorter than that for CIE (45 to 60 min). The staining of CIE films, which we consider necessary, requires an additional 18 h. Carey (1) has summarized the cost of CIE, commercial LA, and COA kits; the range is from $14.70 for the five antisera used in CIE to a per-test cost of $9.10 for Bactigen, $8.35 for Directigen, and $9.00 for Phadebact CSF. However, actual cost comparison is difficult because so many factors are involved, including individual hospital contract prices for kits, the number of specimens that can be processed simultaneously, and the shelf life of the reagents.
Most investigators have indicated that LA is more sensitive than either CIE or COA and that COA is more sensitive than CIE. This report confirms these results when the purified antigens and the reagents provided in the kits were used. However, CIE has been used in this laboratory for 15 years, and as performed clinically it is a very sensitive test. This is shown by the data ( All the products offer advantages to the clinical microbiology laboratory and enable rapid, sensitive, and specific detection of the four major agents of bacterial meningitis. The superiority of these kits over CIE is clear, and they can effectively replace CIE in most laboratories.
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